Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra-abdominal Adipose Tissue, and Serum
Obesity, 10/09/09
Kotronen A et al. – Ceramides may mediate saturated fat–induced insulin resistance, but there are no data comparing ceramide concentrations between human tissues. The human liver contains higher concentrations of ceramides and saturated free fatty acids than either SCfat or IAfat.
Related Articles
Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes
Investigative Ophthalmology and Visual Science, 10/15/09
Relevance Score: 81%
Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition
Journal of Molecular and Cellular Cardiology, 11/17/09
Relevance Score: 80%
DPPH free-radical scavenging ability, total phenolic content, and chemical composition analysis of forty-five kinds of essential oils
International Journal of Cosmetic Science, 10/29/09
Relevance Score: 78%
Long-Chain Polyunsaturated Fatty Acid Composition of Breast Milk in Pre-Eclamptic Mothers
Neonatology, 10/28/09
Relevance Score: 78%
Normal Fatty Acid Concentrations in Young Children With Phenylketonuria
Topics in Clinical Nutrition, 11/16/09
Relevance Score: 70%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Subclinical Atherosclerosis In Young beta-thalassemia Major Patients
Hemoglobin, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


